Plasma homovanillic acid and family history of psychotic disorders in bipolar I patients

Pharmacological Research

Volumn 59, Issue 4, 2009, Pages 269-272

  Zumárraga, Mercedes ^a   Dávila, Ricardo ^a   Basterreche, Nieves ^a   Arrue, Aurora ^a   Goienetxea, Biotza ^a   González Torres, Miguel Angel ^b   Guimón, José ^c  

^a Hospital Psiquiatrico de Zamudio   (Spain)

^b HOSPITAL DE BASURTO   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Bipolar disorder; Family history; Homovanillic acid; Plasma

Indexed keywords

HOMOVANILLIC ACID; LITHIUM; OLANZAPINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BIPOLAR I DISORDER; CONTROLLED STUDY; DRUG DOSE INCREASE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; ANTIMANIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; DRUG THERAPY, COMBINATION; FAMILY HEALTH; FEMALE; HOMOVANILLIC ACID; HUMANS; LITHIUM COMPOUNDS; MALE; PSYCHOTIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 61549142417     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.12.007     Document Type: Article

References (38)

1. Goldberg J.F. Optimizing treatment outcomes in bipolar disorder under ordinary conditions. J Clin Psychiatry 69 Suppl. 3 (2008) 11-19
2. Zimmerman M., Ruggero C.J., Chelminski I., and Young D. Is bipolar disorder overdiagnosed?. J Clin Psychiatry 69 (2008) 935-940
3. Muzina DJ, http://wwwmedscapecom/viewarticle/582125/2008.
4. Hardt J., and Franke P. Validity, reliability and objectivity of the family history method in psychiatry: a meta analysis. Eur Psychiatry 22 (2007) 49-58
5. Cardno A.G., Rijsdijk F.V., Sham P.C., Murray R.M., and McGuffin P. A twin study of genetic relationships between psychotic symptoms. Am J Psychiatry 159 (2002) 539-545
6. Thaker J.G. Neurophysiological endophenotypes across bipolar and schizophrenia psychosis. Schizophr Bull 34 (2008) 760-773
7. Potash J.B., Willour V.L., Chiu Y.F., Simpson S.G., MacKinnon D.F., Pearlson G.D., et al. The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. Am J Psychiatry 158 (2001) 1258-1264
8. Schulze T.G., Hedeker D., Zandi P., Rietschel M., and McMahon F.J. What is familial about familial bipolar disorder? Resemblance among relatives across a broad spectrum of phenotypic characteristics. Arch Gen Psychiatry 63 (2006) 1368-1376
9. Davidson M., Losonczy M.F., Mohs R.C., Lesser J.C., Powchik P., Freed L.B., et al. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients. Neuropsychopharmacology 1 (1987) 17-23
10. Konicki P.E., Owen R.R., Litman R.E., and Pickar D. The acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients. Life Sci 48 (1991) 1411-1416
11. Chou J.C., Czobor P., Tuma I., Charles O., Bebe R., Cooper T.B., et al. Pretreatment plasma HVA and haloperidol response in acute mania. J Affect Disord 59 (2000) 55-59
12. Mazure C.M., and Bowers M.B. Pretreatment plasma HVA predicts neuroleptic response in manic psychosis. J Affect Disord 48 (1998) 83-86
13. Yoshimura R., Nakano Y., Hori H., Ikenouchi A., Ueda N., and Nakamura J. Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders. Hum Psychopharmacol 21 (2006) 433-438
14. Dávila R., Zumárraga M., González-Torres M.A., Andía I., Zamalloa M.I., Basterreche E., et al. Schizophrenia: gender, family risk, and plasma homovanillic acid. Am J Med Genet B Neurospsychiatr Genet 60 (1995) 154-156
15. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured clinical interview for DSM-IV-axis 1 disorders (1996), APA Press, Washington. DC
16. Young R.C., Biggs J.T., Ziegler V.E., and Meyer D.A. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133 (1978) 429-435
17. Zumárraga M., Andía I., Dávila R., and Zamalloa M.I. Homovanillic acid in plasma determined by HPLC with direct injection of plasma filtrates. Clin Chem 40 (1994) 2119-2120
18. Dávila R., Manero E., Zumárraga M., Andía I., Schweitzer J.W., and Friedhoff A.J. Plasma homovanillic acid as a predictor of response to neuroleptics. Arch Gen Psychiatry 45 (1988) 564-567
19. Walker E.F., Bonsall R., and Walder D.J. Plasma hormones and catecholamine metabolites in monozygotic twins discordant for psychosis. Neuropsychiatry Neuropsychol Behav Neurol 15 (2002) 10-17
20. Williams P.D., Puddey I.B., Beilin L.J., and Vandongen R. Genetic influences on plasma catecholamines in human twins. J Clin Endocrinol Metab 77 (1993) 794-799
21. Bacopoulos N.G., Hattox S.E., and Roth R.H. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity. Eur J Pharmacol 55 (1979) 225-236
22. Kendler K.S., and Davis K.L. Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat. Psychiatry Res 13 (1984) 51-58
23. Bacopoulos N.G., Redmond D.E., Baulu J., and Roth R.H. Chronic haloperidol or fluphenazine: effects on dopamine metabolism in brain, cerebrospinal fluid and plasma of Cercopithecus aethiops (vervet monkey). J Pharmacol Exp Ther 212 (1980) 1-5
24. Laduron P.M., and Leysen J.E. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. Biochem Pharmacol 28 (1979) 2161-2165
25. Kendler K.S., Heninger G.R., and Roth R.H. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid. Eur J Pharmacol 71 (1981) 321-326
26. Kaminski R., Powchick P., Warne P.A., Goldstein M., McQueeney R.T., and Davidson M. Measurement of plasma homovanillic acid concentrations in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 14 (1990) 271-287
27. Galinowski A., Castelnau C., Spreux-Varoquaux O., Bourdel M.C., Olie J.P., Loo H., et al. Evolution of plasma homovanillic acid (HVA) levels during treatment in schizo-affective disorder. Prog Neuropsychopharmacol Biol Psychiatry 24 (2000) 1319-1328
28. Dávila R., Zumárraga M., Basterreche N., Arrue A., and Anguiano J.B. Plasma homovanillic acid levels in schizophrenic patients: correlation with negative symptoms. Psychiatry Res 151 (2007) 163-168
29. Duncan E., Bollini A.M., Sanfilipo M., Wieland S., Angrist B., Cooper T.B., et al. Diurnal variation in plasma homovanillic acid in patients with schizophrenia and healthy controls. Schizophr Res 81 (2006) 323-326
30. Goto M., Yoshimura R., Kakihara S., Shinkai K., Yamada Y., Kaji K., et al. Risperidone in the treatment of psychotic depression. Progress Neuropsychopharmacol Biol Psychiatry 4 (2006) 701-707
31. Bowers Jr. M.B., Mazure C.M., Nelson J.C., and Jatlow P.I. Lithium in combination with perphenazine: effect on plasma monoamine metabolites. Biol Psychiatry 32 (1992) 1102-1107
32. Sternberg D.E., Bowers Jr. M.B., Heninger G.R., and Charney D.S. Lithium prevents adaptation of brain dopamine systems to haloperidol in schizophrenic patients. Psychiatry Res 10 (1983) 79-86
33. Kakihara S., Yoshimura R., Shinkai K., Matsumoto C., Goto M., Kaji K., et al. Prediction of response to risperidone treatment with respect to plasma concentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6. Int Clin Psychopharmacol 20 (2005) 71-78
34. Yoshimura R., Ueda N., Shinkai K., and Nakamura J. Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia. Int Clin Psychopharmacol 18 (2003) 107-111
35. Bowers M.B., and Kantrowitz J.T. Elevated plasma dopamine metabolites in cannabis psychosis. Am J Psychiatry 164 (2007) 1615-1616
36. Marcelis M., Suckling J., Hofman P., Woodruff P., Bullmore E., and van Os J. Evidence that brain tissue volumes are associated with HVA reactivity to metabolic stress in schizophrenia. Schizophr Res 86 (2006) 45-53
37. Zumárraga M., Dávila R., González-Torres M.A., Anguiano J.B., Zabalo M.J., Basterreche N., et al. Inter- and intra-individual variability in the levels of plasma homovanillic acid in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 713-719
38. Seeman P., Weinshenker D., Quirion R., Srivastava L.K., Bhardwaj S.K., Grandy D.K., et al. Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis. Proc Natl Acad Sci USA 102 (2005) 3513-3518